ESTEVE
Pharmaceutical ManufacturingCatalonia, Spain1001-5000 Employees
ESTEVE is an international pharmaceutical manufacturing company headquartered in Barcelona, Spain, with a workforce of between 1,001 and 5,000 employees. It serves people with complex diseases through highly specialized solutions via its Europe and USA affiliates and, under the ESTEVE CDMO brand, through contract development and manufacturing of small-molecule APIs with facilities in Spain, Mexico, China and the United States. ESTEVE CDMO operates as a global pure-play contract development and manufacturing organization, developing and manufacturing small-molecule APIs and advanced pharmaceutical intermediates for innovators. In 2025 and 2026 the company expanded its manufacturing capabilities, including a Morton Grove, Illinois, API facility acquired in July 2025 for about $15.5 million, and an expansion of its Celrà facility in Girona, Spain with a 3,000-square-meter production unit for spray drying and purpose-built high-potency containment suites, with plans for additional spray-drying equipment and the launch of a new brand identity at DCAT Week. The company is expanding its U.S. presence through the acquisition of TerSera Therapeutics' Infusion Specialty Therapies Business Unit announced in March 2026, and maintains an ESG strategy that includes B Corp Certification.
1-888-653-2347 
support@leadiq.com 
